“STL Genome Editing 2021…Virtually A New Beginning”
Organized by the Genome Engineering & iPSC Center (GEiC)
January 21-22, 2021
For inquiries contact Xiaoxia Cui.
Presentations in genome editing on cells, animals, plants, & therapeutics by:
January 21, 2021
- Keynote speaker: Charlie Gersbach, Ph.D., Rooney Family Associate Professor of Biomedical Engineering, Duke University
- Ibrahim Kurt, Ph. D. Candidate, Harvard University
- Traver Hart, Assistant Professor, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center
- Tim Peterson, Assistant Professor of Medicine, Washington University in St. Louis
- Shengdar Tsai, Assistant Member of the Department of Hematology, St. Jude Children’s Research Hospital
- John Doench, Director R&D, Institute Scientist, Broad Institute of MIT and Harvard University
- Andrew Anzalone, Head of the Prime Editing Platform at Prime Medicine, Inc.
- Panel Discussion – “Off targeting using nucleases, base editors, prime editors, and in screens”
January 22, 2021
- Alejandro Chavez, Assistant Professor of Pathology & Cell Biology, Columbia University
- Dongsheng Duan, Margaret Proctor Mulligan Professor in Medical Research, School of Medicine, University of Missouri, Columbia
- Aron Geurts, Associate Professor, Department of Physiology, Medical College of Wisconsin
- Xiaoxia Cui, Director of the Genome Engineering & iPSC Center, Washington University in St. Louis
- Andrew Yoo, Associate Professor of Developmental Biology, Washington University in St. Louis
- Martin Kampmann, Associate Professor, Institute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California, San Francisco
- Luke Gilbert, Assistant Professor, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
- Michael Kosicki, Postdoctoral Fellow, Lawrence Berkeley National Laboratory
- Panel Discussion – “On target large deletion, repression as KO alternative, off-targeting potential, continue first days”